## APH: Amphenol Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.2% below STRENGTH zone (3.0-6.0%); PEG 1.16 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($132.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. MercadoLibre stock slides into 2026 as MELI investors eye Feb. 24 earnings and a big U.S. data week**
- Source: ts2.tech | 20260105T030859 | Somewhat-Bullish | Relevance: 63%
- MercadoLibre (MELI) stock closed down 2.0% on Friday at $1,973.70, performing weakly at the start of 2026. Investors are closely watching upcoming U.S. economic data, including the ISM manufacturing index and the December nonfarm payrolls report, as well as MercadoLibre's Q4 2025 earnings provisionally set for February 24. Management changes, with Ariel Szarfsztejn taking over as CEO, also add to the factors influencing investor sentiment in early 2026.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Truist Securiti | $180 | $147 | +22% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($17.10M) |
| Sells | 8 ($29.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (-10.9%)
- Blackrock Inc.: 8.2% (+6.7%)
- FMR, LLC: 8.1% (-8.1%)
- State Street Corpora: 4.6% (+1.2%)
- Price (T.Rowe) Assoc: 3.6% (+5.8%)

### Key Risks

1. Heavy insider selling: $30M sold (8 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.16 suggests fair value with growth premium. Quality metrics strong (ROE 35%, ROA 14%, margin 18%). Balance sheet: strong liquidity (2.1x), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +22%, $162 target (+15%)). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $171.2B |
| Beta | 1.21 |
| 52W Range | $56.45 - $144.37 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.16 |
| Forward P/E | 34.9 |
| Current P/E | 42.3 |
| YoY Growth | 21.3% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at 2.2% (minimal 5-day change). Below STRENGTH zone by 0.8pp (needs >3.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.56), confirming momentum. RSI neutral at 58. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.19% (CS: 69) | Neutral |
| RSI_14 | 58.1 | Neutral |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 1.303x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.89
- **Stop Loss:** $132.47 (5.3% risk)
- **Target:** $147.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 154
- **Position Value:** $21,543.06
- **Portfolio %:** 21.54%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-28 (Est: $0.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $0.93 | +16.5% |
| 2025Q2 | $0.67 | $0.81 | +21.7% |
| 2025Q1 | $0.52 | $0.63 | +21.0% |
| 2024Q4 | $0.50 | $0.55 | +9.2% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*